title: BAVC regimen and autologous bone marrow transplantation for APL patients in second molecular remission: updated results.
authors.forename: S
authors.initials: S
authors.lastname: Capria
authors.forename: R
authors.initials: R
authors.lastname: Latagliata
authors.forename: G
authors.initials: G
authors.lastname: Avvisati
authors.forename: M
authors.initials: M
authors.lastname: Breccia
authors.forename: G
authors.initials: G
authors.lastname: Cimino
authors.forename: D
authors.initials: D
authors.lastname: Diverio
authors.forename: M C
authors.initials: MC
authors.lastname: Petti
authors.forename: G
authors.initials: G
authors.lastname: Meloni
mesh_terms: D000293:Adolescent; D000328:Adult; D000677:Amsacrine / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use*; D016026:Bone Marrow Transplantation / Q000379:methods*; D002330:Carmustine / Q000008:administration & dosage; D002648:Child; D003561:Cytarabine / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D005260:Female; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D012074:Remission Induction; D016879:Salvage Therapy / Q000379:methods; D014182:Transplantation, Autologous
chemical_list: D000677:Amsacrine; D003561:Cytarabine; D005047:Etoposide; D002330:Carmustine